Cardiff Oncology, Inc. (CRDF)
1.58
-0.02
(-1.25%)
USD |
NASDAQ |
Feb 12, 16:00
1.61
+0.03
(+1.90%)
Pre-Market: 09:28
Cardiff Oncology Cash from Investing (Quarterly) : 10.16M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agenus, Inc. | 0.076M |
| Curis, Inc. | 0.00 |
| LadRx Corp. | 0.00 |
| Windtree Therapeutics, Inc. | -0.789M |
| Enzon Pharmaceuticals, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.83M |
| Cash from Financing (Quarterly) | 0.025M |
| Free Cash Flow | -42.27M |
| Free Cash Flow Per Share (Quarterly) | -0.1623 |
| Free Cash Flow to Equity (Quarterly) | -10.68M |
| Free Cash Flow to Firm (Quarterly) | -10.85M |
| Free Cash Flow Yield | -41.93% |